EDGAR Filing Documents for 0001193125-04-162293

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001193125-04-162293

Filing Date

2004-09-27

Accepted

2004-09-27 16:09:05

Documents

Period of Report

2004-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K FOR CORTEX PHARMACEUTICALS, INC.	d10k.htm	10-K	734083
2	AMENDMENT NO. 2 TO THE LEASE AGREEMENT FOR THE COMPANY'S FACILITIES IN IRVINE	dex1079.htm	EX-10.79	81412
3	FORM OF INCENTIVE/NONQUALIFIED STOCK OPTION AGREEMENT	dex1080.htm	EX-10.80	25221
4	FORM OF RESTRICTED STOCK AWARD	dex1081.htm	EX-10.81	46450
5	AMENDMENT TO THE EMPLOYMENT AGREEMENTED DATED MAY 17, 2000 - JAMES H. COLEMAN	dex1082.htm	EX-10.82	3975
6	AMENDMENT TO THE EMPLOYMENT AGREEMENT DATED JUNE 5, 1995 - GARY A. ROGERS, PH.D.	dex1083.htm	EX-10.83	3610
7	CONSENT OF ERNST & YOUNG LLP	dex231.htm	EX-23.1	2019
8	SECTION 302 CERTIFICATION BY CHIEF EXECUTIVE OFFICER	dex311.htm	EX-31.1	9634
9	SECTION 302 CERTIFICATION BY CHIEF FINANCIAL OFFICER	dex312.htm	EX-31.2	9111
10	SECTION 906 CERTIFICATION OF CEO AND CFO	dex32.htm	EX-32	5368
	Complete submission text file	0001193125-04-162293.txt		923797

Mailing Address 15241 BARRANCA PARKWAY IRVINE CA 92718

Business Address 15241 BARRANCA PKWY IRVINE CA 92718 7147273157

CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)